Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capitalworks SSA 1 is a private equity fund managed by Capitalworks, a leading independent alternative asset management firm based in South Africa. The fund is a prominent investor in the Sub-Saharan African healthcare landscape, most notably through its strategic partnership and ownership stake in IQVIA Africa. This investment positions the fund at the center of the region's clinical research and healthcare data sectors, supporting the operations of the world's largest contract research organization (CRO) in local markets. Additionally, Capitalworks SSA 1 has been instrumental in the restructuring of Ascendis Health, a major South African healthcare company with a broad portfolio of pharmaceutical and medical device products. The fund focuses on providing growth capital and strategic expertise to market-leading businesses, driving operational excellence and expanding access to healthcare services across the continent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capitalworks SSA 1.